iShares Microcap ETF (IWC)

Retail optimism for One Stop Systems comes amid the company’s about $1.2 million pre-production order from a U.S. defense prime contractor announced last week.

The Food and Drug Administration said in a letter to the company that it is unable to approve its EBVALLO application in present form, citing inadequate evidence of effectiveness for accelerated approval.

Cineverse expects Giant Worldwide to contribute pro forma revenue of $15-17 million in fiscal year 2027.

Nutriband has agreed to sell 90% of its stake in its subsidiary Pocono Pharmaceuticals for $5 million.

Senti Biopharma shares rallied in premarket trading on Tuesday after its cancer treatment received a positive designation from the U.S. FDA.

The company said it will work with the agency to reach a resolution and expressed confidence in its clinical data.

HL60 leukemia cells were treated with Telomir-1, which produced a clear, dose-dependent reduction in viable leukemia cells, indicating strong activity in this aggressive human model, the company said.

Matt Kinsella says quantum technology will be a major technological shift for humanity over the next decade.

BigBear retail is buzzing about the stock taking off and rallying through the year-end.

Strive, following its merger with Asset Entities in mid-September, announced plans to become a Bitcoin holding company.

Novartis has agreed to buy Avidity Biosciences in a deal valued at $72 per share.

In an amended regulatory filing, AiRWA confirmed a stake built by director Michael Anthony Belfiore.

Kezar announced on Thursday that it was unable to align with the FDA on a potential registrational clinical trial of Zetomipzomib in patients with relapsed and refractory autoimmune hepatitis.

With the recent VDR contracts, the company’s near-term VDR pipeline and recent bookings totaled $40 million, a 100% increase from August.

New York, NY – October 9, 2025 – After an extended period of lagging behind their larger counterparts, micro-cap stocks have roared back with a vengeance in 2025, staging a significant rally that has seen them outpace major market indices. This surprising resurgence, particularly in the latter half of the year, signals

Citron recommended that investors should own three Churchill Corp shares for every single Rigetti stock they own.